Yuflyma®
Rheumatoid arthritis, IBD
MarketedApproved
Key Facts
About Celltrion
Celltrion's mission is to promote patient health by making advanced biologics affordable and accessible globally. It has achieved this by evolving from a contract manufacturer into a vertically integrated powerhouse, becoming the world's leading biosimilar producer with a robust pipeline. Its core strategy leverages massive, FDA/EMA-certified manufacturing capacity, a direct global sales network, and a deep R&D pipeline spanning biosimilars and novel biologics to drive growth and secure long-term market leadership.
View full company profileTherapeutic Areas
Other Rheumatoid arthritis, IBD Drugs
| Drug | Company | Phase |
|---|---|---|
| Remsima® | Celltrion | Marketed |
| Remsima® SC | Celltrion | Marketed |